Germany, France, Italy and Spain said they would resume using | Financial Times Ukraine news

Germany, France, Italy and Spain said they would resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator said there was a 'clear scientific conclusion' that the jab was 'safe and effective'.

Delay to the vaccine rollout in Europe is threatening to undermine immunisation programmes in developing countries that rely almost exclusively on the Oxford/AstraZeneca jab. Follow our tracker to find out the latest on the race to vaccinate the world's population.

The number of infections and the rate of vaccinations are rising in India, prompting pressure from the government to assess domestic demand and then export accordingly. To read more, take out a trial subscription.

We’ll be back on Monday to bring you more free-to-read coverage of the coronavirus pandemic.